Literature DB >> 1452679

Use of the E test to predict high-level resistance to aminoglycosides among enterococci.

M L Sanchez1, M S Barrett, R N Jones.   

Abstract

The E test and the reference agar dilution methods were compared for detecting high-level aminoglycoside resistance (HLAR) among 71 selected clinical isolates, including 62 Enterococcus faecalis and 9 Enterococcus faecium isolates. High-level gentamicin resistance alone was found in 11% (5 E. faecalis and 3 E. faecium strains) and high-level streptomycin resistance was found in 42% (28 E. faecalis, 2 E. faecium strains) of the strains tested, and 31% of the strains demonstrated high-level resistance to both antimicrobial agents (21 E. faecalis and 1 E. faecium strains). The E test detected all HLAR populations, but the streptomycin strip may require recalibration to achieve absolute MIC comparisons with the reference value (twofold less) or the use of an alternative interpretive resistance breakpoint, e.g., > 1,000 micrograms/ml. By the E test, MIC results indicate that ampicillin, imipenem, penicillin, piperacillin, and vancomycin remain active against the HLAR E. faecalis isolates; however, these tested drugs were less effective on the HLAR E. faecium isolates (< 50%).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452679      PMCID: PMC270578          DOI: 10.1128/jcm.30.11.3030-3032.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and Enterobacteriaceae producing potent beta-lactamases.

Authors:  M L Sanchez; M S Barrett; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1992-07       Impact factor: 2.803

2.  Species identification and antibiotic resistance patterns of the enterococci.

Authors:  E A Bryce; S J Zemcov; A M Clarke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

Review 3.  Antimicrobial resistance among enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 4.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 5.  Therapy of enterococcal infections.

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

6.  Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients.

Authors:  J W Gray; D Stewart; S J Pedler
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; J E Schulz
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

8.  Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis.

Authors:  M Louie; A E Simor; S Szeto; M Patel; B Kreiswirth; D E Low
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

  8 in total
  4 in total

1.  Resistant enterococci--mechanisms, laboratory detection and control in hospitals.

Authors:  J J Wade; A H Uttley
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

Review 2.  Antimicrobial Susceptibility Testing for Enterococci.

Authors:  Ayesha Khan; William R Miller; Dierdre Axell-House; Jose M Munita; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2022-06-13       Impact factor: 11.677

3.  Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp.

Authors:  J E Schulz; D F Sahm
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

4.  High level resistance to aminoglycosides in urinary isolates of enterococci.

Authors:  P Jyothi; Bc Metri; Bv Peerapur
Journal:  Ann Med Health Sci Res       Date:  2014-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.